Anti-infective immunotherapy for treating hospital acquired infections.
DOWNLOAD PDF  l  GO TO ARTICLE

BROTHERS IN ARMS: BioPharma and CROs collaborating in early drug discovery.
DOWNLOAD PDF   l  GO TO ARTICLE

EPIGENETIC TARGETS: on the verge of becoming a major new category for successful drug research.
DOWNLOAD PDF  l  GO TO ARTICLE

INDIVIDUALISED SYSTEMS MEDICINE: next-generation precision cancer medicine and
drug positioning.
DOWNLOAD PDF  l  GO TO ARTICLE

Managing data challenges in the new R&D environment.
DOWNLOAD PDF  l  GO TO ARTICLE

The development of cell-based assays for pain drug discovery.
DOWNLOAD PDF  l  GO TO ARTICLE

A systemic malady: the pervasive problem of misconduct in the biomedical sciences part I: issues and causes.
DOWNLOAD PDF  l  GO TO ARTICLE

Therapeutic Drug Repurposing, Repositioning and Rescue Part III: market exclusivity using Intellectual Property and regulatory pathways.
DOWNLOAD PDF  l  GO TO ARTICLE

When two are not enough: lead optimisation beyond matched pairs.
DOWNLOAD PDF  l  GO TO ARTICLE

The increasing impact of precision research models on drug discovery and development.
DOWNLOAD PDF   l  GO TO ARTICLE

RNA based drugs and vaccines will launch a new era of information driven medicine.
DOWNLOAD PDF  l  GO TO ARTICLE

The California Institute for Regenerative Medicine’s Human iPSC Initiative
DOWNLOAD PDF  l  GO TO ARTICLE

The benefits of not competing.
DOWNLOAD PDF  l  GO TO ARTICLE

Overcoming the ‘disruption dip’ in the aftermath of M&A.
DOWNLOAD PDF  l  GO TO ARTICLE

New developments in single cell separation and analysis technologies.
DOWNLOAD PDF  l  GO TO ARTICLE

How neutron science has enabled innovation in drug design and delivery.
DOWNLOAD PDF  l  GO TO ARTICLE

CAR-T : Looking beyond the hype.
DOWNLOAD PDF  l  GO TO ARTICLE

Drug discovery in a multi-omics world.
DOWNLOAD PDF   l  GO TO ARTICLE

Phenotypic Drug Discovery: striving towards the highest level of biological relevance.
DOWNLOAD PDF  l  GO TO ARTICLE

Seeing within: Magnetic Resonance Imaging in drug development.
DOWNLOAD PDF  l  GO TO ARTICLE

The use of syngeneic models for the discovery of targets for combination therapy and predictive biomarkers of immunotherapy efficacy.
DOWNLOAD PDF  l  GO TO ARTICLE

Therapeutic Drug Repurposing, Repositioning and Rescue Part IV: Financial model and analysis.
DOWNLOAD PDF  l  GO TO ARTICLE

Valuation in portfolio management.
DOWNLOAD PDF  l  GO TO ARTICLE